CVR number 10036992
Industry 47.7810 Other retail sale of new goods in specialised stores

GANER & ROBENHAGEN. NORDJYDSK KONTAKTLINSEKLINIK A/S

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Bankruptcy risk for industry  3.8% 3.8% 3.8% 3.8% 3.8%  
Bankruptcy risk  0.9% 0.8% 0.8% 0.9% 1.0%  
Credit score (0-100)  91 90 91 89 84  
Credit rating  A A AA A A  
Credit limit (kDKK)  436.8 549.2 660.2 650.5 465.5  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Net sales  0 0 0 0 0  
Gross profit  5,593 6,272 6,774 7,936 7,810  
EBITDA  1,867 2,479 2,869 3,538 3,530  
EBIT  1,798 2,415 2,815 3,496 3,501  
Pre-tax profit (PTP)  1,798.1 2,404.8 2,799.7 3,484.8 3,506.2  
Net earnings  1,399.6 1,842.1 2,177.3 2,715.5 2,732.0  
Pre-tax profit without non-rec. items  1,798 2,405 2,800 3,485 3,506  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Tangible assets total  193 130 75.3 33.9 4.8  
Shareholders equity total  3,400 3,842 4,177 4,716 4,732  
Interest-bearing liabilities  0.0 0.0 0.0 18.0 0.0  
Balance sheet total (assets)  5,546 6,122 6,699 7,616 7,675  
Net Debt  -951 -1,565 -1,988 -2,359 -2,418  
 
See the entire balance sheet

Volume 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  5,593 6,272 6,774 7,936 7,810  
Gross profit growth  9.0% 12.1% 8.0% 17.2% -1.6%  
Employees  6 7 7 7 7  
Employee growth %  0.0% 16.7% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  5,546 6,122 6,699 7,616 7,675  
Balance sheet change%  0.8% 10.4% 9.4% 13.7% 0.8%  
Added value  1,866.7 2,478.7 2,868.9 3,550.8 3,530.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -103 -127 -109 -83 -58  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  32.2% 38.5% 41.6% 44.1% 44.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  32.5% 41.4% 43.9% 48.8% 45.9%  
ROI %  45.7% 57.7% 62.1% 70.9% 67.0%  
ROE %  41.2% 50.9% 54.3% 61.1% 57.8%  

Solidity 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Equity ratio %  61.3% 62.8% 62.4% 61.9% 61.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -51.0% -63.1% -69.3% -66.7% -68.5%  
Gearing %  0.0% 0.0% 0.0% 0.4% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 129.8% 10.1%  

Liquidity 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Quick Ratio  2.4 2.7 2.6 2.5 2.5  
Current Ratio  3.3 3.5 3.2 3.2 3.1  
Cash and cash equivalent  951.5 1,565.2 1,988.4 2,376.8 2,417.5  

Capital use efficiency 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  3,750.0 4,296.7 4,561.3 5,180.4 5,233.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Net sales / employee  0 0 0 0 0  
Added value / employee  311 354 410 507 504  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  311 354 410 505 504  
EBIT / employee  300 345 402 499 500  
Net earnings / employee  233 263 311 388 390